Business Development

Azur Pharma actively seeks to in-license or acquire FDA approved and late-stage development pharmaceutical products, particularly in the CNS, women’s health or urology areas.

Azur Pharma's management team has extensive experience in completing pharmaceutical transactions in a timely and collaborative manner, to the benefit of both parties.

Azur Pharma has experience in a range of transaction structures including in-licensing and acquisition transactions, distribution, royalty and co-promotion agreements, and research and development collaborations.

If you are interested in speaking with us please contact:

David Brabazon
CFO, Senior Vice President Finance
E-mail: david.brabazon@azurpharma.com
Telephone: +353 1 634 4183